The effect of Ginkgo biloba and Camellia sinensis extracts on psychological state and glycemic control in patients with type 2 diabetes mellitus

Natural Product Communications

Volumn 9, Issue 9, 2014, Pages 1345-1350

  Lasaite, Lina ^a   Spadiene, Asta ^a   Savickiene, Nijole ^a   Skesters, Andrejs ^b   Silova, Alise ^b  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b RIGA STRADINS UNIVERSITY   (Latvia)

Author keywords

Emotional state; Ginkgo biloba L. extract; Green tea ( Camellia sinensis L.) extract; Perceived stress; Quality of life; Type 2 diabetes mellitus

Indexed keywords

GINKGO BILOBA EXTRACT; GLYCOSYLATED HEMOGLOBIN; GREEN TEA EXTRACT; HEMOGLOBIN A1C; PLACEBO; ANTIOXIDANT; GLUCOSE BLOOD LEVEL; PLANT EXTRACT;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CAMELLIA SINENSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EVALUATION STUDY; FEMALE; GINKGO BILOBA; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTIVE THRESHOLD; PLANT LEAF; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; CHEMISTRY; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PSYCHOLOGY;

AGED; ANTIOXIDANTS; BLOOD GLUCOSE; CAMELLIA SINENSIS; DIABETES MELLITUS, TYPE 2; FEMALE; GINKGO BILOBA; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; QUALITY OF LIFE;

EID: 84907501817     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1400900931     Document Type: Article

References (48)

1. Aiyegoro OA, Okoh AI. (2010) Preliminary phytochemical screening and in vitro antioxidant activities of the aqueous extract of Helicrysum longifolium DC. BMC Complementary and Alternative Medicine, 10, 21-28.
2. Henriksen EJ, Diamond-Stanic MK, Marchionne EM. (2011) Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radical Biology Medicine, 51, 993-999.
3. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkosi A, Hilpert KF. (2002) Bioactive compounds in food: their role in the prevention of cardiovascular disease and cancer. American Journal of Medicine, 113, 715-885.
4. Wright EJr, Scism-Bacon JL, Glass L. (2006) Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycemia. International Journal of Clinical Practice, 60, 308-14.
5. Atabek ME, Vatansev H, Erkul I. (2004) Oxidative stress in childhood obesity. Journal Pediatric Endocrinology and Metabolism, 17, 1063-1068.
6. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS. (2000) Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE) randomized placebo-controlled trial. Lancet, 356, 1213-1218.
7. Simon GE, Vonkorff M, Barlow W. (1995) Health care costs of primary care patients with recognized depression. Archives of General Psychiatry, 52, 850-6.
8. Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB. (2008) Anxiety disorders and comorbid medical illness. General Hospital Psychiatry, 30, 208-225.
9. Ball S, Goddard A, Shekhar A. (2002) Evaluating and treating anxiety disorders in medical settings. Postgraduate Medicine, 48, 317-321.
10. Salim S, Asghar M, Chugh G, Taneja M, Xia Z, Saha K. (2010) Oxidative stress: A potential recipe for anxiety, hypertension and insulin resistance. Brain Research, 1359, 178-185.
11. Souza CG, Moreira JD, Siqueira IR, Pereira AG, Rieger DK, Souza DO, Souza TM, Portela LV, Perry ML. (2007) Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sciences, 27, 198-203.
12. Hovatta I, Tennant RS, Helton R, Marr RA, Singer O, Redwine JM, et al. (2005) Glyoxalase I and glutathione reductase I regulate anxiety in mice. Nature, 438, 662-666.
13. Masood A, Nadeem A, Mustafa SJ, O'Donnell JM. (2008) Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. Journal of Pharmacology and Experimental Therapeutics, 326, 369-379.
14. Yadav BS, Yadav R. (2005) Spices as antimicrobials and antioxidants in foods. Beverage and Food World Magazine, 36-41.
15. Rahman K. (2007) Studies on free radicals, antioxidants, and co-factors. Clinical Interventions in Ageing, 2, 219-36.
16. Mahdavi DL, Salunkhe DK. (1995) Toxicological aspects of food antioxidant. In Food Antioxidants. Mahdavi DL, Deshpande SS, Salunkhe DK. (Eds). Marcel Dekker, New York, 267-293.
17. Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M. (2014) Herbal antioxidant in clinical practice: A review. Asian Pacific Journal of Tropical Biomedicine, 4, 78-84
18. Lu JM, Lin PH, Yao Q, Chen C. (2010) Chemical and molecular mechanisms of antioxidants: Experimental approaches and model systems. Journal of Cellular and Molecular Medicine, 14, 840-860.
19. Gulati V, Harding IH, Palombo EA. (2012) Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia. BMC Complementary and Alternative Medicine, 12, 77.
20. Zou YX, Shen WZ, Liao ST, Liu F, Zheng SQ, Blumberg JB, Chen CYO. (2014) Mulberry leaf phenolics ameliorate hyperglycemia-induced oxidative stress and stabilize mitochondrial membrane potential in HepG2 cells. International Journal of Food Sciences and Nutrition, Early Online: 1-7. DOI: 10.3109/09637486.2014.940285.
21. Michael RP. (2006) Flavonoids attenuate cardiovascular disease, inhibit phosphodiesterase, and modulate lipid homeostasis in adipose tissue and liver. Experimental Biology and Medicine, 231, 1287-1299.
22. Pandey KB, Rizvi SI. (2009) Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Medicine and Cellular Longevity, 2, 270-278.
23. Rizvi SI, Zaid MA, Anis R, Mishra N. (2005) Protective role of tea catechins against oxidation-induced damage of type 2 diabetic erythrocytes. Clinical and Experimental Pharmacology and Physiology, 32, 70-75.
24. Kanwar J, Taskeen M, Mohammad I, Huo C, Chan TH, Dou QP. (2012) Recent advances on tea polyphenols. Frontiers in Bioscience (Elite Ed), 4, 111-131
25. Khan N, Mukhtar H. (2007) Tea polyphenols for health promotion. Life Science, 81, 519-533
26. Sinija VR, Mishra HN. (2008) Green tea: Health benefits. Journal of Nutritional & Environmental Medicine, 17, 232-242.
27. Wichtl M. (2004) Herbal Drugs and Phytopharmaceuticals: A Handbook for Practice on a Scientific Basis. Medpharm Scientific Publishers, Stuttgart, Germany, 251-254.
28. European Scientific Cooperative on Phytotherapy (ESCOP). (2003) Gingko folium. In ESCOP, ed. ESCOP Monographs: The scientific foundation for Herbal Medicinal Products, 2nd Edition. Thieme, Stuttgart, New York, 178-210.
29. Bridi R, Crossetti FP, Steffen VM, Henriques AT. (2001) The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. Phytotherapy Research, 15, 449-451
30. Chacko SM, Thambi PT, Kuttan R, Nishigaki I. (2010) Beneficial effects of green tea: A literature review. Chinese Medicine, 5, 13-21
31. Shi C, Liu J, Wu F, Yew DT. (2010) Ginkgo biloba extract in Alzheimer's disease: From action mechanisms to medical practice. International Journal of Molecular Sciences, 11, 107-123.
32. Spadiene A, Savickiene N, Skesters A, Silova A, Rodovicius H. (2012) The effects of Ginkgo biloba L. and Camellia sinensis L. extracts on oxidative stress in patients with type 2 diabetes. African Journal of Pharmacy and Pharmacology. 6, 3080-3085
33. Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Martini F, Scaglione GL, Speranza D, Santini S, Zuppi C, Ghirlanda G. (2009) Role of asymmetric-dimethyl-l-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus. Diabetes Research and Clinical Practice, 86, 173-176.
34. Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Santini SA, Zuppi C, Ghirlanda G. (2010) Oxidative stress, nitric oxide, and diabetes. The Review of Diabetic Studies, 7, 15-25.
35. Rahimi R, Nikfar S, Larijani B, Abdollani M. (2005) A review on the role of antioxidants in the management of diabetes and its complications. Biomedicine and Pharmacotherapy, 59, 365-373.
36. Paolisso G, Esposito R, Dalessio MA, Barbieri M. (1999) Primary and secondary prevention of atherosclerosis: Is there a role of antioxidants? Diabetes and Metabolism, 25, 298-306.
37. Smith JV, Luo Y. (2003) Elevation of oxidative free radicals in Altzheimer's disease models can be attenuated by Ginkgo biloba extract Egb761. Journal of Altzheimer's Disease, 5, 287-300.
38. Gohil K, Packer L. (2002) Global gene expression analysis identifies cell and tissue specific actions of Ginkgo biloba extract Egb761. Cell and Molecular Biology, 48, 625-631.
39. Tanaka S, Han LK, Zheng YN, Okuda H. (2004) Effects of the flavonoid fraction from Ginkgo biloba extract on the postprandial blood glucose elevation in rats. Yakugaku Zassi, 124, 605-611.
40. Choi SE, Shin HC, Kim HE, Lee SJ, Jang HJ, Lee KW, Kang Y. (2007) Involvement of Ca2+, CaMK II and PKA in Egb761-induced insulin secretion in INS-1 cells. Journal of Ethnopharmacology, 110, 49-55.
41. Kudolo GB. (2001) The effects of 3-month ingestion of Ginkgo biloba extract (Egb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus. Journal of Clinical Pharmacology, 41, 600-611.
42. Tobe EH. (2013) Mitochondrial dysfunction, oxidative stress, and major depressive disorder. Neuropsychiatric Disease and Treatment, 9, 567-573.
43. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. (1993) A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clinical Science, 84, 407-412.
44. Esterbauer H, Cheeseman KH. (1990) Determination of aldehydic lipid-peroxidation products - Malonaldehyde and 4-hydroxynonenal. Methods in Enzymology, 186, 407-421.
45. Cohen S, Kamarck T, Mermelstein R. (1983) A global measure of perceived stress. Journal of Health and Social Behavior, 24, 385-396.
46. McNair O, Lorr M, Droppleman LF. (1992) EDITS Manual for the Profile of Mood States. Educational and Institutional Testing Service, San Diego (Calif.).
47. WHO (1996) WHOQOL-BREF: introduction, administration, scoring and generic version of the assessment. World Health, Organization. Field Trail Version.
48. Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. (2008) Development of a brief diabetes distress screening instrument. Annals of Family Medicine, 6, 246-252.